Overview

Effectiveness & Safety of Ovine Enoxaparin Sodium to Originator Enoxaparin in Non-ST-Segment Elevation Acute Coronary Syndrome (NSTEACS) Patients: a Multicenter, Non-randomized, Open-label, Non-inferiority Trial

Status:
Recruiting

Trial end date:
2023-12-31

Target enrollment:

Participant gender:

Summary

The aim of this study is evaluating safety and effectiveness of Ovine Enoxaparin Sodium in Non-ST-Segment Elevation Acute Coronary Syndrome (NSTEACS) Patients

Phase:

Phase 4

Details

Lead Sponsor:

PT Bio Farma

Treatments:

Enoxaparin
Enoxaparin sodium